Filed: 5/15/2023ACC: 0001012975-23-000217
📋 What this filing means
ARCH VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $207.18M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$207.18M
Total AUM (reported)
56.87M
Total Shares
Allocation by class
COM$207.18M100.0%
Portfolio Concentration
Top 3$162.95M78.7%
4–10$44.23M21.3%
Top 3 weight
78.7%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 56.87M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
56.87M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings8
Rows:
EQRX, INC.
SOLEShares36.34M
TypeSH
Market value$70.49M
34.02%
Sole
0.00
Shared
0.00
None
36.34M
DENALI THERAPEUTICS, INC.
SOLEShares2.57M
TypeSH
Market value$59.18M
28.57%
Sole
0.00
Shared
0.00
None
2.57M
ERASCA, INC.
SOLEShares11.06M
TypeSH
Market value$33.28M
16.06%
Sole
0.00
Shared
0.00
None
11.06M
VERVE THERAPEUTICS, INC.
SOLEShares2.01M
TypeSH
Market value$28.97M
13.98%
Sole
0.00
Shared
0.00
None
2.01M
KARUNA THERAPEUTICS, INC.
SOLEShares30K
TypeSH
Market value$5.45M
2.63%
Sole
0.00
Shared
0.00
None
30K
SINGULAR GENOMICS SYSTEMS, INC.
SOLEShares3.80M
TypeSH
Market value$4.60M
2.22%
Sole
0.00
Shared
0.00
None
3.80M
NATERA, INC.
SOLEShares64.44K
TypeSH
Market value$3.58M
1.73%
Sole
0.00
Shared
0.00
None
64.44K
UNITY BIOTECHNOLOGY, INC.
SOLEShares1M
TypeSH
Market value$1.64M
0.79%
Sole
0.00
Shared
0.00
None
1M
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
EQRX, INC.SOLE | COM | 36.34M | SH | $70.49M 34.02% | 0.00 | 0.00 | 36.34M |
DENALI THERAPEUTICS, INC.SOLE | COM | 2.57M | SH | $59.18M 28.57% | 0.00 | 0.00 | 2.57M |
ERASCA, INC.SOLE | COM | 11.06M | SH | $33.28M 16.06% | 0.00 | 0.00 | 11.06M |
VERVE THERAPEUTICS, INC.SOLE | COM | 2.01M | SH | $28.97M 13.98% | 0.00 | 0.00 | 2.01M |
KARUNA THERAPEUTICS, INC.SOLE | COM | 30K | SH | $5.45M 2.63% | 0.00 | 0.00 | 30K |
SINGULAR GENOMICS SYSTEMS, INC.SOLE | COM | 3.80M | SH | $4.60M 2.22% | 0.00 | 0.00 | 3.80M |
NATERA, INC.SOLE | COM | 64.44K | SH | $3.58M 1.73% | 0.00 | 0.00 | 64.44K |
UNITY BIOTECHNOLOGY, INC.SOLE | COM | 1M | SH | $1.64M 0.79% | 0.00 | 0.00 | 1M |